Technical Analysis for NVS - Novartis AG

Grade Last Price % Change Price Change
F 85.47 -0.44% -0.38
NVS closed down 0.44 percent on Monday, February 6, 2023, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Flat Down Down

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Walk Weakness -0.44%
Stochastic Reached Oversold Weakness -0.44%
Outside Day Range Expansion -0.44%
Below Lower BB Weakness -0.44%
Down 3 Days in a Row Weakness -0.44%
Lower Bollinger Band Touch Weakness -0.44%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 3 hours ago
60 Minute Opening Range Breakdown about 5 hours ago
Fell Below 200 DMA about 5 hours ago
200 DMA Support about 6 hours ago
2x Volume Pace about 7 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Novartis AG Description

Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism, respiratory, and other medicines. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines, and blood testing and molecular diagnostics products to prevent the spread of infectious diseases. Its Consumer Health division consists of two divisions, including over-the-counter medicines that offer readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Biotechnology Pharmaceutical Drugs Infectious Diseases Pharmacy Eye Medication Neuroscience Antibiotics Ophthalmology Animal Health Ophthalmic Eyewear Molecular Diagnostics Blood Test Metabolism Prescription Drugs Disposable Products Healthcare Products Active Pharmaceutical Ingredients Disposable Product Primary Care Lenses Contact Lens Contact Lenses Surgical Equipment Eye Care Over The Counter Drug Diagnostics Products Intraocular Lens Lens Care Products Eye Care Products Veterinary Products

Is NVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 94.25
52 Week Low 74.095
Average Volume 1,979,977
200-Day Moving Average 85.18
50-Day Moving Average 90.39
20-Day Moving Average 90.18
10-Day Moving Average 89.01
Average True Range 1.58
RSI 30.56
ADX 31.57
+DI 14.47
-DI 42.42
Chandelier Exit (Long, 3 ATRs) 88.50
Chandelier Exit (Short, 3 ATRs) 89.88
Upper Bollinger Bands 94.53
Lower Bollinger Band 85.83
Percent B (%b) -0.04
BandWidth 9.64
MACD Line -0.97
MACD Signal Line -0.19
MACD Histogram -0.7832
Fundamentals Value
Market Cap 194.4 Billion
Num Shares 2.27 Billion
EPS 3.09
Price-to-Earnings (P/E) Ratio 27.69
Price-to-Sales 4.14
Price-to-Book 3.72
PEG Ratio 2.78
Dividend 3.09
Dividend Yield 3.62%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 86.33
Resistance 3 (R3) 86.31 86.00 86.18
Resistance 2 (R2) 86.00 85.79 86.01 86.13
Resistance 1 (R1) 85.74 85.65 85.59 85.76 86.09
Pivot Point 85.43 85.43 85.36 85.44 85.43
Support 1 (S1) 85.17 85.22 85.02 85.19 84.85
Support 2 (S2) 84.86 85.08 84.87 84.81
Support 3 (S3) 84.60 84.86 84.76
Support 4 (S4) 84.62